Amit Saxena

Robert Herfkens, situated in Stanford, CA, is a renowned establishment dedicated to advancing patient care, research excellence, and medical education. With strong ties to Stanford University, this institution introduces cutting-edge therapies and progressive techniques across diverse medical domains such as cancer treatment, cardiovascular services, neurological care, orthopedics, and organ transplantation. At Robert Herfkens, a network of clinical facilities, outpatient centers, and specialized initiatives converge to provide a wealth of medical proficiency administered by proficient healthcare professionals. Through a synergistic model, Robert Herfkens unites physicians, nurses, researchers, and specialists to foster patient well-being, drive clinical knowledge forward, and continually enhance medical methodologies. This institution stands as a beacon of innovation and dedication, embodying a commitment to pushing the boundaries of medical care while ensuring a holistic approach to healthcare delivery. Generated using this brand's available information

David Hovsepian, MD, is a highly qualified interventional radiologist and clinical professor specializing in pediatric radiology. With board certifications in both interventional and diagnostic radiology, he has extensive training and experience, including fellowships and residencies at prestigious institutions. Dr. Hovsepian has contributed significantly to the field through numerous publications, focusing on innovative techniques and advancements in interventional radiology. His commitment to quality and safety in radiology is evident through his administrative roles and ongoing contributions to medical literature. Generated from the website

Dr. Boris Heifets, MD, PhD, is a board certified anesthesiologist who specializes in providing anesthesia for neurological surgery. He has practiced at Stanford since 2010. After completing residency training at Stanford, Dr. Heifets completed fellowship training in neuroanesthesiology, also at Stanford. In addition to treating patients, Dr. Heifets also directs both clinical research and basic neuroscience. His research group studies how new rapid acting psychiatric therapies, like ketamine, MDMA and psilocybin, produce lasting changes in nervous system function, behavior, and therapeutic outcomes.